Einstein Center One

Philadelphia, Pennsylvania 19115

0 studies enrolling now · 4 studies all time

What they study most

ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Breast Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Lung Cancer AJCC v8, Stage IIA Lung Non-Small Cell Carcinoma AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7

Studies at this site

• Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) — Running, not enrolling
• Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) — Running, not enrolling
• Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) — Running, not enrolling
• Breast Cancer WEight Loss Study (BWEL Study) — Running, not enrolling